Our results confirmed that TRIM25 was involved in the malignant progression of breast cancer and PTX resistance, and that TRIM25 participates in the regulation of ubiquitination level and protein degradation of BRD7 through the ubiquitin-proteasome pathway. This evidence concerns the gene BRD7 and breast carcinoma.